Tucker Asset Management’s YieldMax MRNA Option Income Strategy ETF MRNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$338 Sell
23
-9
-28% -$144 ﹤0.01% 1008
2025
Q3
$565 Hold
32
﹤0.01% 308
2025
Q2
$750 Sell
32
-1
-3% -$25 ﹤0.01% 287
2025
Q1
$914 Sell
33
-1
-3% -$38 ﹤0.01% 294
2024
Q4
$1.77K Hold
34
﹤0.01% 1235
2024
Q3
$2.99K Hold
34
﹤0.01% 1068
2024
Q2
$5.2K Buy
34
+5
+17% +$984 ﹤0.01% 1043
2024
Q1
$6.08K Buy
+29
New +$5.94K ﹤0.01% 1012

Other funds holding MRNY

Tucker Asset Management's MRNY Position: Q4 2025 in Review

Tucker Asset Management reduced its YieldMax MRNA Option Income Strategy ETF (MRNY) stake by 28% in Q4 2025, selling an estimated $144 and leaving 23 shares worth $338. The position accounts for ﹤0.01% of the portfolio, ranked #1008.

Tucker Asset Management first reported a position in MRNY in Q1 2024 and has held it in 8 quarters since. The position peaked at $6.08K in Q1 2024. 14 funds tracked by Wall St. Rank hold MRNY as of Q4 2025.

  • Tucker Asset Management held 23 shares of YieldMax MRNA Option Income Strategy ETF worth $338 as of Q4 2025.
  • Tucker Asset Management sold 9 YieldMax MRNA Option Income Strategy ETF shares in Q4 2025, an estimated $144.
  • YieldMax MRNA Option Income Strategy ETF made up ﹤0.01% of Tucker Asset Management's portfolio in Q4 2025, its #1008 holding.
  • Tucker Asset Management first reported a position in YieldMax MRNA Option Income Strategy ETF in Q1 2024 and has held it in 8 quarters since.
  • Tucker Asset Management's YieldMax MRNA Option Income Strategy ETF position peaked at $6.08K in Q1 2024.
  • 14 funds tracked by Wall St. Rank held YieldMax MRNA Option Income Strategy ETF as of Q4 2025.

Based on Tucker Asset Management's 13F filing for Q4 2025, filed 5 Feb 2026.